Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
-
To determine the relationship between inpatient glycemic control and hospital readmission in patients with congestive heart failure (CHF). ⋯ Increasing glucose exposure, but not glycemic variability, was associated with higher risk of readmission between 30 and 90 days in patients with CHF. Prospective studies are needed to confirm or refute these results.
-
To study changes in bone mineral density (BMD) and a bone resorption marker in elderly men who received off-label zoledronic acid for osteoporosis treatment. ⋯ Our data suggest that 4 mg of intravenously administered zoledronic acid is an effective treatment for increasing BMD in a "real-world" population of men with osteoporosis. The prolonged suppression of urinary NTx after zoledronic acid infusion raises the question of whether this treatment could be given less frequently than every year. The changes seen in BMD during a mean period of 2 years were similar to those reported in clinical studies with alendronate therapy in men and zoledronic acid treatment in women.